ANZGOG’s Fund for New Research Grant Program supports the research ideas to shape the future of gynaecological cancer care.

The next advance in gynaecological cancer treatment and care can begin with a research question that has not yet been answered.

ANZGOG’s Fund for New Research Grant Program supports promising research at an important early stage of development, helping researchers generate the evidence and insights needed to progress towards larger research projects and, where appropriate, future clinical trials.

The Fund supports investigator-led research across gynaecological cancers, providing an opportunity to test new ideas, undertake pilot or feasibility work and develop the evidence needed to take promising research to its next stage.

Early Career Researchers are particularly encouraged to apply.

2026 Fund for New Research
With significant support from ANZGOG donors, the 2026 Fund will provide four research grants:

  • Endometrial cancer focused surgical study (1 grant only, up to $55,000)
  • Leiomyosarcoma focused project (1 grant only, up to $65,000)
  • Endometrial cancer focused project (1 grant only, up to $100,000)
  • Clinical or pre-clinical ovarian carcinosarcoma project (1 grant only, up to $50,000)

Priority will be given to projects which complete the form correctly and describe how the project will lead to a larger study or clinical trial. The 2026 Fund for New Research applications must align with the current ANZGOG strategic plan (2023 – 2028).

Clinical projects may include:

  • Pilot or feasibility studies (if intended to generate data to support preparation for a larger research project).
  • Sub-studies of clinical studies already underway, such as clinical studies, QOL etc.
  • Projects that have commenced recruitment are not eligible.
  • Projects proposing a clinical trial in Australia and/or New Zealand led by international counterparts are not eligible.

Translational projects may include:

  • New translational sub-studies of current or prior trials.

Pre-clinical projects may include:

  • Drug therapies.
  • Research that will contribute to clinical trial design or refinement.

Who can apply?

  • The Fund for New Research is open to ANZGOG members only.
  • Early Career Researchers are particularly encouraged to apply.
  • Each ANZGOG member may submit a maximum of one application, including as a co-investigator.

How to apply: Applications, including all required attachments, must be emailed to Heshani Nesfield heshani.nesfield@anzgog.org.au

Grant applications close Monday, 28 September 2026.

DOWNLOAD GRANT APPLICATION FORM

  • ANZGOG members only
    (Early Career Researchers are encouraged to apply). Please note: Pending ANZGOG Members are eligible to apply. Apply for ANZGOG membership.
  • A maximum of one application by each member (including 1 for co-investigators) may be submitted.
  • No institutional overhead will be supported.

Research Projects and Priority

Priority will be given to projects which complete the form correctly and describe how the project will lead to a larger study or clinical trial. [Clinical, translational, pre-clinical and survivorship projects will be assessed separately]. The 2026 Fund for New Research applications must align with the current ANZGOG strategic plan (2023-2028).

Clinical projects may include:

  • Pilot or feasibility studies (if intended to generate data to support preparation for a larger research project).
  • Sub-studies of clinical studies already underway, such as clinical studies, QOL etc.
  • Projects that have commenced recruitment are not eligible.
  • Projects proposing a clinical trial in Australia and/or New Zealand led by international counterparts are not eligible.

Translational projects may include:

  • New translational sub-studies of current or prior trials.
  • Drug therapies for molecular subtypes.
  • Research that will contribute to clinical trial design or refinement.

Note:  Pre-clinical and translational concepts will be assessed on potential clinical application, considering the likelihood of findings either leading to a clinical trial, assisting in the design, or supporting the translational component of a clinical trial.

ANZGOG is seeking projects that have the potential to lead to a future clinical trial. Clinical and pre-clinical projects will be assessed separately.

  • Pilot or feasibility studies (if intended to generate data to support preparation for a larger research project).
  • Sub-studies of clinical studies already underway, such as clinical application studies, QOL etc.
  • Any clinical study that meets ANZGOG’s research priorities.
  • Initiatives working on a drug therapy for molecular subtypes.
  • Research that contributes to clinical trial design or refinement.
  • New translational sub-studies of current or prior trials.

NB: pre-clinical concepts will be assessed on potential clinical application or significance as relevant.

Submissions must:

  • Have direct alignment with ANZGOG’s Research Goals
  • Be clearly feasible and achievable within the budget and time-frame.
  • Be fully funded either by this ANZGOG grant or in combination with other funding. Proof of other funding is required before contracting. NB: If other funding required and not secured within 3 months of ANZGOG’s offer, the Fund for New Research Grant offer will be withdrawn.

Scientific review – by the ANZGOG Research Advisory Committee – at the 01 October 2026 meeting.

Funding and grant review – by the ANZGOG Grant Panel. This panel consists of ANZGOG members representing the major clinical specialities for gynaecological oncology and experienced investigators reviewing against set Fund for New Research criteria.

29 September 2026 Grant Applications close
01 October 2026 RAC meeting
2-27 October 2026 Grant Panel review
[for research projects approved by the RAC]
26 November 2026 Board of Directors meeting
27 November 2026 Final applicant notifications
December 2026/January 2027 Contracting with successful applicants

The project will be noted as an ANZGOG study and will be recognised on all publications with the words “Research and funding collaboration with ANZGOG.”

The ANZGOG Board of Directors make the final decision on funds available and approves the grant panel recommendation.

ANZGOG is deeply grateful to the generous donors who make opportunities like the Fund for New Research possible. Their support enables researchers to explore promising ideas, generate new evidence and take important steps towards the research that could shape the future of gynaecological cancer. If you would like to learn more about supporting the Fund for New Research and helping create opportunities for the next generation of gynaecological cancer research, please contact Bec Weeden Bec.Weeden@anzgog.org.au

Useful Links:

Fund for New Research 2026 Application Form

ANZGOG strategic plan (2023 – 2028)

20 Years Improving Life for Women – Part One

20 Years Improving Life for Women – Part Two